" class="no-js "lang="en-US"> Sajid Javid Archives - Medtech Alert
Wednesday, June 12, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Digital Revolution to Bust COVID Backlogs and Deliver More Tailored Care for Patients

People across the country will benefit from faster, more personalised healthcare, following a digital revolution […]

Patients to Have Earlier Access to Cutting-edge Treatments on NHS

NHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks […]

One Million Checks Delivered By NHS ‘One Stop Shops’

NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]

New Clinical Trials Deal Struck to Better Protect World From Future Pandemics

Millions of people across the world will be better protected from future pandemics thanks to […]

Hundreds of Patients to Get Life-extending Lung Cancer Drug on the NHS

Hundreds of people with a form of the most common form of lung cancer could […]

New State-Of-The-Art NHS Hospital To Help Tackle Covid Backlog

A new ‘planned care’ hospital dedicated to non-emergency treatment is due to open in Berkshire […]

NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer

A targeted new drug for a rare and aggressive form of lung cancer will be […]

New UK-wide Ambitions to Accelerate Genomic Research and Drive Innovation in Healthcare

Patients across the UK are set to benefit from faster cancer diagnosis and innovative new […]

Life-extending Injection for Blood Cancer Available on the NHS

A life-extending injection for a fatal form of blood cancer will be available to around […]

Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS

A revolutionary targeted drug for lung cancer will be made available to anyone who is […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more